Cargando…
A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
Development of effective malaria vaccines requires delivery platforms to enhance the immunogenicity and efficacy of the target antigens. This is particularly challenging for transmission-blocking malaria vaccines (TBVs), and specifically for those based on the Pfs25 antigen, that need to elicit very...
Autores principales: | Marini, Arianna, Zhou, Yu, Li, Yuanyuan, Taylor, Iona J., Leneghan, Darren B., Jin, Jing, Zaric, Marija, Mekhaiel, David, Long, Carole A., Miura, Kazutoyo, Biswas, Sumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921968/ https://www.ncbi.nlm.nih.gov/pubmed/31921185 http://dx.doi.org/10.3389/fimmu.2019.02931 |
Ejemplares similares
-
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
por: Gupta, Ekta, et al.
Publicado: (2023) -
Potentiating the
Immune Responses of HBsAg-VLP Vaccine
Using a Polyphosphoester-Based Cationic Polymer Adjuvant
por: Liu, Xuhan, et al.
Publicado: (2023) -
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
por: Kim, Kwang Min, et al.
Publicado: (2011) -
Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011) -
Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy
por: Cao, Zhenhuan, et al.
Publicado: (2020)